Bioprinting functional tissues.

Cell density Engraftment Functional tissue bioprinting Heterogeneity Innervation Mechanics Transplant Vascularization

Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 07 10 2018
revised: 31 12 2018
accepted: 09 01 2019
pubmed: 15 1 2019
medline: 30 7 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

Despite the numerous lives that have been saved since the first successful procedure in 1954, organ transplant has several shortcomings which prevent it from becoming a more comprehensive solution for medical care than it is today. There is a considerable shortage of organ donors, leading to patient death in many cases. In addition, patients require lifelong immunosuppression to prevent graft rejection postoperatively. With such issues in mind, recent research has focused on possible solutions for the lack of access to donor organs and rejections, with the possibility of using the patient's own cells and tissues for treatment showing enormous potential. Three-dimensional (3D) bioprinting is a rapidly emerging technology, which holds great promise for fabrication of functional tissues and organs. Bioprinting offers the means of utilizing a patient's cells to design and fabricate constructs for replacement of diseased tissues and organs. It enables the precise positioning of cells and biologics in an automated and high throughput manner. Several studies have shown the promise of 3D bioprinting. However, many problems must be overcome before the generation of functional tissues with biologically-relevant scale is possible. Specific focus on the functionality of bioprinted tissues is required prior to clinical translation. In this perspective, this paper discusses the challenges of functionalization of bioprinted tissue under eight dimensions: biomimicry, cell density, vascularization, innervation, heterogeneity, engraftment, mechanics, and tissue-specific function, and strives to inform the reader with directions in bioprinting complex and volumetric tissues. STATEMENT OF SIGNIFICANCE: With thousands of patients dying each year waiting for an organ transplant, bioprinted tissues and organs show the potential to eliminate this ever-increasing organ shortage crisis. However, this potential can only be realized by better understanding the functionality of the organ and developing the ability to translate this to the bioprinting methodologies. Considering the rate at which the field is currently expanding, it is reasonable to expect bioprinting to become an integral component of regenerative medicine. For this purpose, this paper discusses several factors that are critical for printing functional tissues including cell density, vascularization, innervation, heterogeneity, engraftment, mechanics, and tissue-specific function, and inform the reader with future directions in bioprinting complex and volumetric tissues.

Identifiants

pubmed: 30639351
pii: S1742-7061(19)30029-7
doi: 10.1016/j.actbio.2019.01.009
pmc: PMC6625952
mid: NIHMS1518443
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-49

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD055882
Pays : United States

Informations de copyright

Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Références

J Tissue Eng Regen Med. 2011 Apr;5(4):e17-35
pubmed: 21413155
Sci Rep. 2017 Jul 4;7(1):4566
pubmed: 28676704
J Biomed Mater Res. 2000 Sep 5;51(3):376-82
pubmed: 10880079
Ann Med. 2008;40(4):268-80
pubmed: 18428020
Drug Discov Today. 2016 Aug;21(8):1257-71
pubmed: 27086009
Ophthalmologe. 2003 Mar;100(3):209-15
pubmed: 12640550
Anat Rec A Discov Mol Cell Evol Biol. 2003 Jun;272(2):491-6
pubmed: 12740942
Nanomedicine. 2014 Jan;10(1):235-46
pubmed: 23792331
Biofabrication. 2016 Dec 05;9(1):015006
pubmed: 27917823
Saudi Pharm J. 2017 May;25(4):469-476
pubmed: 28579877
PLoS One. 2012;7(8):e42569
pubmed: 22880036
Tissue Eng Part C Methods. 2012 Jan;18(1):33-44
pubmed: 21854293
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):10012-7
pubmed: 22665791
Biomaterials. 2014 Sep;35(28):8092-102
pubmed: 24965886
Sci Rep. 2017 Jun 12;7(1):3323
pubmed: 28607361
Biofabrication. 2016 Sep 23;8(3):032002
pubmed: 27658612
Biomaterials. 2017 Apr;124:106-115
pubmed: 28192772
EMBO Rep. 2000 Jul;1(1):4-6
pubmed: 11256622
Tissue Eng. 2005 Nov-Dec;11(11-12):1817-23
pubmed: 16411827
Biofabrication. 2014 Sep;6(3):035020
pubmed: 25048797
Br J Plast Surg. 1988 Mar;41(2):182-6
pubmed: 3280056
PLoS One. 2015 Sep 01;10(9):e0136681
pubmed: 26325298
Stem Cells Dev. 2005 Jun;14(3):252-65
pubmed: 15969620
Sci Rep. 2016 Dec 14;6:39140
pubmed: 27966623
Biofabrication. 2013 Dec;5(4):045007
pubmed: 24192236
J Biomed Mater Res A. 2017 Jan;105(1):274-283
pubmed: 26860782
Nat Biotechnol. 2016 Mar;34(3):312-9
pubmed: 26878319
Biofabrication. 2015 Oct 21;7(4):044102
pubmed: 26486521
Sci Rep. 2015 Nov 25;5:17203
pubmed: 26603915
Sci Rep. 2016 Jul 20;6:29977
pubmed: 27436509
Lab Chip. 2014 Jan 21;14(2):268-75
pubmed: 24257507
Cartilage. 2021 Jan;12(1):76-92
pubmed: 30373384
Organogenesis. 2013 Jul-Sep;9(3):168
pubmed: 23974170
Biotechnol Adv. 2016 Jul-Aug;34(4):422-434
pubmed: 26724184
Adv Mater. 2012 Jan 17;24(3):391-6
pubmed: 22161949
Lab Chip. 2014 Jul 7;14(13):2202-11
pubmed: 24860845
Biomaterials. 2009 Oct;30(31):6221-7
pubmed: 19695697
Biomaterials. 2015 May;49:77-89
pubmed: 25725557
Biotechnol Bioeng. 2008 Apr 1;99(5):1250-60
pubmed: 17929317
Biotechnol Adv. 2017 Mar - Apr;35(2):217-239
pubmed: 28057483
ACS Nano. 2013 Apr 23;7(4):2891-7
pubmed: 23560817
Biofabrication. 2016 Jan 12;8(1):015007
pubmed: 26756962
Biofabrication. 2015 Jun 17;7(3):035003
pubmed: 26081669
Biofabrication. 2015 Dec 22;7(4):045011
pubmed: 26693735
Biomaterials. 2016 Jan;76:321-43
pubmed: 26561931
Hepatobiliary Pancreat Dis Int. 2016 Oct;15(5):512-518
pubmed: 27733321
Bioelectromagnetics. 2011 May;32(4):283-90
pubmed: 21452358
Trends Biotechnol. 2017 Nov;35(11):1025-1034
pubmed: 28789815
Adv Mater. 2014 May 21;26(19):3124-30
pubmed: 24550124
Dev Dyn. 2000 Jun;218(2):235-59
pubmed: 10842355
Tissue Eng Part C Methods. 2016 Jan;22(1):1-7
pubmed: 26414863
Nat Med. 2016 Mar;22(3):306-11
pubmed: 26808346
Sci Rep. 2017 Nov 6;7(1):14610
pubmed: 29097768
J Tissue Eng Regen Med. 2018 Mar;12(3):611-621
pubmed: 28512850
J Burn Care Res. 2010 Jan-Feb;31(1):158-75
pubmed: 20061852
Nat Commun. 2018 Jan 22;9(1):323
pubmed: 29358641
Nat Biotechnol. 2014 Aug;32(8):773-85
pubmed: 25093879
Sci Rep. 2017 Feb 13;7:42556
pubmed: 28211911
Biomater Res. 2016 Apr 25;20:12
pubmed: 27114828
Genes Dis. 2017 Dec;4(4):185-195
pubmed: 29911158
Adv Healthc Mater. 2017 Feb;6(4):
pubmed: 27976537
Biomaterials. 2017 Jan;112:264-274
pubmed: 27770630
Small. 2006 Feb;2(2):216-9
pubmed: 17193023
PLoS One. 2013 Oct 04;8(10):e76396
pubmed: 24124557
Sci Technol Adv Mater. 2016 Apr 8;17(1):136-148
pubmed: 27877865
Biomacromolecules. 2015 May 11;16(5):1489-96
pubmed: 25806996
Biomaterials. 2010 Oct;31(28):7250-6
pubmed: 20580082
Transplant Proc. 2012 May;44(4):1158-61
pubmed: 22564652
Nat Cell Biol. 2014 Jun;16(6):502-4
pubmed: 24875737
Int J Mol Sci. 2015 Mar 11;16(3):5517-27
pubmed: 25768338
Tissue Eng Part C Methods. 2018 Feb;24(2):74-88
pubmed: 29050528
J Biomed Mater Res A. 2013 May;101(5):1255-64
pubmed: 23015540
Lab Chip. 2012 Aug 21;12(16):2815-22
pubmed: 22767334
Biomaterials. 2005 Jan;26(1):93-9
pubmed: 15193884
Adv Healthc Mater. 2017 Jan;6(1):
pubmed: 27995751
Tissue Eng Part A. 2011 May;17(9-10):1445-55
pubmed: 21247342
Biotechnol J. 2015 Oct;10(10):1568-77
pubmed: 25641582
Cell Mol Immunol. 2015 Jul;12(4):444-55
pubmed: 25242276
Sci Rep. 2017 May 11;7(1):1778
pubmed: 28496103
Biofabrication. 2015 Jul 02;7(3):035004
pubmed: 26133398
Bioengineering (Basel). 2017 Aug 18;4(3):
pubmed: 28952550
Small. 2015 Sep 9;11(34):4237-66
pubmed: 26122917
Stem Cells Transl Med. 2012 Nov;1(11):792-802
pubmed: 23197691
Plast Reconstr Surg Glob Open. 2017 Feb 15;5(2):e1227
pubmed: 28280669
J Biomed Mater Res B Appl Biomater. 2017 Jul;105(5):1016-1028
pubmed: 26922876
J Vis Exp. 2017 Jul 2;(125):
pubmed: 28715377
Cell. 2006 Aug 25;126(4):677-89
pubmed: 16923388
Biotechnol Bioeng. 2012 Sep;109(9):2357-68
pubmed: 22508498
Acta Biomater. 2015 Oct;25:24-34
pubmed: 26210285
Tissue Eng Part A. 2008 Mar;14(3):433-40
pubmed: 18333795
J Biomed Mater Res. 2001 Jun 15;55(4):503-11
pubmed: 11288078
J Orthop Res. 2014 Dec;32(12):1652-7
pubmed: 25196502
Biomaterials. 2005 Jun;26(18):3911-8
pubmed: 15626438
Expert Rev Med Devices. 2011 Sep;8(5):607-26
pubmed: 22026626
Biomaterials. 2016 Sep;102:20-42
pubmed: 27318933
Regen Med. 2015;10(5):665-79
pubmed: 26038952
Curr Pharm Biotechnol. 2013;14(1):91-7
pubmed: 23570054
Biofabrication. 2018 Mar 16;10(3):035003
pubmed: 29451122
Adv Sci (Weinh). 2016 Apr 15;3(8):1600058
pubmed: 27818910
Adv Healthc Mater. 2017 Aug;6(16):
pubmed: 28558161
Stem Cell Res Ther. 2014 Jun 10;5(3):78
pubmed: 24916098
Immunol Cell Biol. 2013 Jan;91(1):32-9
pubmed: 23295415
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2206-11
pubmed: 26858399
PLoS One. 2014 Sep 18;9(9):e108252
pubmed: 25233468
Sci Rep. 2017 Aug 1;7(1):7004
pubmed: 28765636
J Mater Chem B. 2017 Nov 28;5(44):8854-8864
pubmed: 32264279
Anal Chem. 2014 Apr 1;86(7):3240-53
pubmed: 24432804
Angew Chem Int Ed Engl. 2014 May 19;53(21):5380-4
pubmed: 24711342
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):E3414-23
pubmed: 23184971
J Funct Biomater. 2012 Jul 19;3(3):480-96
pubmed: 24955628
Lab Chip. 2016 Jul 5;16(14):2618-25
pubmed: 27302471
J Biomater Appl. 2016 Aug;31(2):181-92
pubmed: 27252227
Sci Rep. 2016 Aug 30;6:32184
pubmed: 27572698
Biomaterials. 2009 Oct;30(30):5910-7
pubmed: 19664819
Biofabrication. 2016 Oct 07;8(4):045002
pubmed: 27716628
Biomaterials. 2014 Jan;35(1):49-62
pubmed: 24112804
Cells Tissues Organs. 2016;202(5-6):319-328
pubmed: 27595401
Tissue Eng Part A. 2008 Jan;14(1):41-8
pubmed: 18333803
Biofabrication. 2010 Jun;2(2):022001
pubmed: 20811127
Cell Transplant. 2012;21(12):2711-21
pubmed: 22963757
Biotechnol Bioeng. 2017 Jan;114(1):208-216
pubmed: 27345768
J Biomed Mater Res B Appl Biomater. 2004 Nov 15;71(2):313-21
pubmed: 15386400
Biomicrofluidics. 2017 Aug 01;11(4):044109
pubmed: 28852429
Front Bioeng Biotechnol. 2017 Apr 05;5:23
pubmed: 28424770
Biofabrication. 2018 Nov 23;11(1):015009
pubmed: 30468153
Sci Rep. 2016 Feb 22;6:21685
pubmed: 26899876
Dev Dyn. 2015 May;244(5):629-40
pubmed: 25613150
PLoS One. 2017 Feb 13;12(2):e0171448
pubmed: 28192527
J Tissue Eng Regen Med. 2018 Jul;12(7):1798-1821
pubmed: 29757529
Biotechnol Bioeng. 2016 Jul;113(7):1381-402
pubmed: 26615050
Stem Cell Rev Rep. 2017 Feb;13(1):7-16
pubmed: 27592701
Methods Mol Biol. 2018;1577:95-102
pubmed: 28456953
Bioact Mater. 2018 Feb 20;3(2):144-156
pubmed: 29744452
ACS Biomater Sci Eng. 2016 Oct 10;2(10):1743-1751
pubmed: 33440472
Sci Rep. 2016 Jun 27;6:28714
pubmed: 27346373
Tissue Eng Part A. 2012 Jun;18(11-12):1304-12
pubmed: 22394017
Theranostics. 2017 Jul 22;7(12):3118-3137
pubmed: 28839468
Adv Mater. 2016 Jan 27;28(4):677-84
pubmed: 26606883
Biofabrication. 2015 Sep 16;7(3):031002
pubmed: 26373778
Osteoarthritis Cartilage. 2003 Dec;11(12):879-90
pubmed: 14629964
Biofabrication. 2013 Jun;5(2):025004
pubmed: 23458889
Biofabrication. 2012 Sep;4(3):035005
pubmed: 22914604
Nat Commun. 2014 Jun 02;5:3935
pubmed: 24887553
J Tissue Eng Regen Med. 2018 Mar;12(3):e1826-e1835
pubmed: 29105354
Tissue Eng Part A. 2008 Jan;14(1):127-33
pubmed: 18333811
Adv Healthc Mater. 2012 Nov;1(6):762-7
pubmed: 23184828
Biomaterials. 2011 Dec;32(35):9218-30
pubmed: 21911255
Acta Biomater. 2017 Mar 15;51:1-20
pubmed: 28087487
ACS Nano. 2015 Mar 24;9(3):3109-18
pubmed: 25674809
Ann Surg. 2017 Jul;266(1):48-58
pubmed: 28594678
Gels. 2018 Sep 06;4(3):
pubmed: 30674851
Curr Drug Discov Technol. 2015;12(4):218-24
pubmed: 26778084
Liver Int. 2006 Feb;26(1):116-24
pubmed: 16420517
Nat Biotechnol. 2002 Jul;20(7):689-96
pubmed: 12089553
Nat Commun. 2014 May 08;5:3774
pubmed: 24805923
Stem Cells Transl Med. 2017 Oct;6(10):1940-1948
pubmed: 28836738
Trends Biotechnol. 2013 Jan;31(1):10-9
pubmed: 23260439
Nanotechnology. 2014 Apr 11;25(14):145101
pubmed: 24632802
Biofabrication. 2016 Dec 02;9(1):012001
pubmed: 27910820
Biotechnol Bioeng. 2012 Dec;109(12):3152-60
pubmed: 22767299
Exp Cell Res. 1988 Dec;179(2):362-73
pubmed: 3191947
Biomaterials. 2012 Feb;33(6):1782-90
pubmed: 22136718
Brain Plast. 2015 Oct 9;1(1):5-27
pubmed: 29765833
Tissue Eng Part A. 2015 Jan;21(1-2):224-33
pubmed: 25051339
Biomater Sci. 2013 Jul 4;1(7):763-773
pubmed: 32481829
J Surg Res. 2001 Aug;99(2):282-7
pubmed: 11469898

Auteurs

Ashley N Leberfinger (AN)

Department of Surgery, Penn State University College of Medicine, Hershey, PA 17033, USA.

Shantanab Dinda (S)

Department of Industrial and Manufacturing Engineering, The Pennsylvania State University, University Park, PA 16802, USA; The Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.

Yang Wu (Y)

The Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA; Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park, PA 16802, USA.

Srinivas V Koduru (SV)

Department of Surgery, Penn State University College of Medicine, Hershey, PA 17033, USA.

Veli Ozbolat (V)

The Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA; Ceyhan Engineering Faculty, Cukurova University, Ceyhan, Adana 01950, Turkey.

Dino J Ravnic (DJ)

Department of Surgery, Penn State University College of Medicine, Hershey, PA 17033, USA.

Ibrahim T Ozbolat (IT)

The Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA; Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park, PA 16802, USA; Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA. Electronic address: ito1@psu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH